
Smartphone-based prescription digital treatments for autoimmune conditions like fibromyalgia.
Swing Therapeutics, founded with the mission to revolutionize chronic illness management, focuses on developing smartphone-based prescription digital treatments. Their core vision is to empower individuals with chronic conditions to thrive through innovative, evidence-based digital therapies. The company's flagship product, Stanza, is an FDA-cleared digital therapy specifically designed to alleviate symptoms of fibromyalgia, available by prescription.
Notable affiliated individuals include a team of passionate scientists, clinicians, and technologists collaborating with leading researchers. Swing Therapeutics has garnered attention for its significant achievement in obtaining FDA clearance for Stanza, marking a pivotal step in digital health solutions. The company's impact lies in offering a non-invasive, accessible treatment option that enhances the quality of life for those with chronic conditions.

Empower Therapeutics

Better Therapeutics

Blue Note Therapeutics

metaMe Health
metamehealth.com

SimpleTherapy
simpletherapy.com

Pear Therapeutics

Kaia Health

Oui Therapeutics

Sway Medical
swaymedical.com

Click Therapeutics

MicroHealth
microhealth.com

Jeevam Health
jeevamhealth.com

MedRhythms

Mindset Health
mindsethealth.com

Digbi Health
digbihealth.com
Companies similar to Swing Therapeutics include Empower Therapeutics, Better Therapeutics, Blue Note Therapeutics and metaMe Health.
Swing Therapeutics was founded in 2019.
Swing Therapeutics' headquarters is located in San Francisco, CA, US.
Swing Therapeutics' most recent funding round was for $10.3M (USD) in June 2022.
As of Jun 16, 2022, Swing Therapeutics has raised a total of $19.3M (USD).
Swing Therapeutics has 25 employees as of Feb 5, 2024.